(19)
(11) EP 4 256 348 A1

(12)

(43) Date of publication:
11.10.2023 Bulletin 2023/41

(21) Application number: 21831406.0

(22) Date of filing: 30.11.2021
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/6896; G01N 2333/948
(86) International application number:
PCT/US2021/061215
(87) International publication number:
WO 2022/119841 (09.06.2022 Gazette 2022/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 01.12.2020 US 202063120062 P
05.04.2021 US 202163170873 P

(71) Applicant: Abbott Laboratories
Abbott Park, IL 60064 (US)

(72) Inventors:
  • MCQUISTON, Beth
    Abbott Park, Illinois 60064 (US)
  • DATWYLER, Saul
    Abbott Park, Illinois 60064 (US)
  • CHANDRAN, Raj
    Abbott Park, IL 60064 (US)
  • MARINO, Jaime
    Abbott Park, IL 60064 (US)
  • ZHANG, Hongwei
    Abbott Park, IL 60064 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) USE OF ONE OR MORE BIOMARKERS TO DETERMINE TRAUMATIC BRAIN INJURY (TBI) IN A SUBJECT HAVING RECEIVED A HEAD COMPUTERIZED TOMOGRAPHY SCAN THAT IS NEGATIVE FOR A TBI